These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 15489115)

  • 1. Task force 1: The ACCF and AHA codes of conduct in human subjects research.
    Alpert JS; Shine KI; Adams RJ; Antman EM; Kavey RE; Friedman L; Frye RL; Harrington RA; Korn D; Merz JF; Ofili E
    J Am Coll Cardiol; 2004 Oct; 44(8):1724-8. PubMed ID: 15489115
    [No Abstract]   [Full Text] [Related]  

  • 2. Task force 2: Investigator participation in clinical research.
    Califf RM; Nissen SE; DeMaria AN; Ohman EM; Pitt B; Willerson JT; Bilheimer DW; Cohn JN; Feigal DW; Hampson L; Lorell BH; Pepine CJ; Popp RL
    J Am Coll Cardiol; 2004 Oct; 44(8):1729-36. PubMed ID: 15489116
    [No Abstract]   [Full Text] [Related]  

  • 3. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 4. Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications.
    Jacobs AK; Lindsay BD; Bellande BJ; Fonarow GC; Nishimura RA; Shah PM; Annex BH; Fuster V; Gibbons RJ; Jackson MJ; Rahimtoola SH
    J Am Coll Cardiol; 2004 Oct; 44(8):1736-40. PubMed ID: 15489117
    [No Abstract]   [Full Text] [Related]  

  • 5. Research column: protection of children as subjects in research.
    Nelson AE
    J Pediatr Oncol Nurs; 2003; 20(3):141-3. PubMed ID: 12776262
    [No Abstract]   [Full Text] [Related]  

  • 6. Task force 4: Appropriate clinical care and issues of "self-referral".
    Ritchie JL; Wolk MJ; Hirshfeld JW; Messer JV; Peterson ED; Prystowsky EN; Gardner TJ; Kimball HR; Popp RL; Smaha L; Smith SC; Wann LS
    J Am Coll Cardiol; 2004 Oct; 44(8):1740-6. PubMed ID: 15489118
    [No Abstract]   [Full Text] [Related]  

  • 7. Task force 6: Code of conduct for staff and volunteer leadership.
    Douglas PS; Ryan TJ; Beller GA; Hines EF; Livingston DW; McEntee CW; Brown NA; Collishaw KJ; Garson A; Robertson RM; Smith SC; Whitman GR
    J Am Coll Cardiol; 2004 Oct; 44(8):1750-3. PubMed ID: 15489120
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent in clinical research: policies and practices in Singapore.
    Ramachandran AJ
    J Biolaw Bus; 2003; 6(1):65-75. PubMed ID: 15239181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatism as a complementary approach to legislation: closing regulatory gaps in human subject research.
    Vernillo A
    Am J Bioeth; 2008 Nov; 8(11):15-7. PubMed ID: 19061099
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of interest in human subjects research.
    Groeger JS; Barnes M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 13. In harm's way: research subjects who are decisionally impaired.
    Sundram CJ
    J Health Care Law Policy; 1998; 1(1):36-65. PubMed ID: 15573429
    [No Abstract]   [Full Text] [Related]  

  • 14. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 15. Research involving persons with mental disorders that may affect decisionmaking capacity--executive summary.
    US National Bioethics Advisory Commission
    J Int Bioethique; 2002 Mar; 13(1):109-14. PubMed ID: 15038373
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children as research subjects: a proposal to revise the current federal regulations using a moral framework.
    Ross LF
    Stanford Law Pol Rev; 1997; 8(1):159-76. PubMed ID: 16528858
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

  • 19. Growing public scrutiny of FDA clinical trials: ethical and regulatory compliance to avoid "uninformed consent" and financial conflicts of interest.
    Ronai SE
    Conn Med; 2001 Nov; 65(11):661-6. PubMed ID: 11766553
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.